1236667-40-5

1236667-40-5 structure

Name: Ifidancitinib
Chemical Name: N-(4-{[(6S)-4-Hydroxy-2-(hydroxymethyl)-7,8-dihydro-6H-cyclopenta[g]quinazolin-6-yl](2-propyn-1-yl)amino}benzoyl)-γ-glutamylglutamic acid
CAS Number: 1236667-40-5
Molecular Formula: C₂₀H₁₈FN₅O₃
Molecular Weight: 395.39
Catalog: Signaling Pathways Epigenetics JAK
Create Date: 2022-01-01 08:11:54
Modify Date: 2024-01-14 21:22:10
Ifidancitinib is a potent and selective inhibitor of JAK kinases 1/3. Ifidancitinib can be used in studies of allergies, asthma and autoimmune diseases[1].

Name	N-(4-{[(6S)-4-Hydroxy-2-(hydroxymethyl)-7,8-dihydro-6H-cyclopenta[g]quinazolin-6-yl](2-propyn-1-yl)amino}benzoyl)-γ-glutamylglutamic acid
Synonyms	N-(4-{[(6S)-4-Hydroxy-2-(hydroxymethyl)-7,8-dihydro-6H-cyclopenta[g]quinazolin-6-yl](2-propyn-1-yl)amino}benzoyl)-γ-glutamylglutamic acid Glutamic acid, N-[4-[[(6S)-7,8-dihydro-4-hydroxy-2-(hydroxymethyl)-6H-cyclopenta[g]quinazolin-6-yl]-2-propyn-1-ylamino]benzoyl]-γ-glutamyl-

Description	Ifidancitinib is a potent and selective inhibitor of JAK kinases 1/3. Ifidancitinib can be used in studies of allergies, asthma and autoimmune diseases[1].
Related Catalog	Signaling Pathways >> JAK/STAT Signaling >> JAK Signaling Pathways >> Epigenetics >> JAK Signaling Pathways >> Stem Cell/Wnt >> JAK Research Areas >> Others
References	[1]. Li, Hui; Heckrodt, Thilo J.; Chen, Yan; Mcmurtrie, Darren John; Taylor, Vanessa; Singh, Rajinder; Ding, Pingyu; Yen, Rose.Preparation of phenylaminopyrimidinylaminooxobenzooxazole derivatives for use as JAK kinase inhibitors. WO2012015972A1